Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:

NCT ID: NCT06371131 Recruiting - Clinical trials for Postoperative Nausea and Vomiting

Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

Postoperative nausea and vomiting is one of the most common postoperative complications second only to postoperative pain. Studies have reported that without any antiemetic prevention treatment, the overall incidence of PONV in surgical operations is up to 20-30%, and the incidence of PONV in high-risk patients such as thyroid surgery is even up to 70-80%. PONV not only increased discomfort and prolonged hospital stay; Severe cases can lead to wound dehysis, acid-base imbalance, water and electrolyte metabolism disorders, seriously affect the prognosis of patients. Although various prevention and treatment measures have been adopted in clinical practice, it still cannot be completely eliminated. Therefore, postoperative nausea and vomiting of thyroid is still a concern in clinical anesthesia work, so it is urgent to explore more simple and effective measures to prevent thyroid PONV. SGB is the injection of local anesthetics into loose connective tissue containing stellate ganglion. It has a clear effect on postoperative analgesia of thyroid surgery, and can play a certain role in preventing thyroid PONV by reducing the application of perioperative opioids. Few studies have reported that the incidence of PONV can be significantly reduced after the application of SGB in patients with thyroid surgery, which provides a certain basis for the prevention of thyroid PONV. Therefore, this study aims to explore the effect of right stellate ganglion block on preventing postoperative nausea and vomiting of thyroid, and to explore the possible mechanism of action.

NCT ID: NCT06366958 Not yet recruiting - Hand Ganglion Clinical Trials

Arthroscopic Versus Open Excision of Dorsal Wrist Ganglion

Start date: May 2, 2024
Phase: N/A
Study type: Interventional

compare recurrence rates after open and arthroscopic excision of dorsal wrist ganglion

NCT ID: NCT06354673 Enrolling by invitation - Clinical trials for Paroxysmal Sympathetic Hyperactivity

Stellate Ganglion Block Combined With Dexmedetomidine or Subanesthetic Ketamine Infusion for Treatment of Neurostorm.

Start date: April 4, 2024
Phase: N/A
Study type: Interventional

Neurostorming is a sudden and exaggerated stress response as a result of damage to the brain. With appropriate treatment and time, there is hope for individuals to overcome storming, regain consciousness, and work towards successfully recovering from brain injury. Most treatments for neurostorming involve the use of medications only such as dexmedetomidine, opioids, gabapentin and propofol to address secondary complications like high blood pressure and fever. These medications focus on slowing the body's stress response or relaxing the body. Stellate ganglion block (SGB) is a promising therapy for paroxysmal sympathetic hyperactivity (PSH), overcoming the limitations of systemic medications and may serve to recalibrate aberrant autonomic states. Ketamine is a potent dissociative agent which has sedative, analgesic and anesthetic properties beside its sympathomimetic effect. Its combination with stellate ganglion block is to oppose its sympathomimetic effect. Dexmedetomidine has analgesic and sedative effect which inhibits the sympathetic nerve activity through its action on the α2 receptor in the spinal cord. Hypothesis: Null hypothesis: There is no difference between the effects of stellate ganglion block combined with dexmedetomidine or subanesthetic ketamine infusion for treatment of neurostorm after traumatic brain injury in critically ill patients.Alternative hypothesis: There is a difference between the effects of stellate ganglion block combined with dexmedetomidine or subanesthetic ketamine infusion for treatment of neurostorm after traumatic brain injury in critically ill patients.which has sedative, analgesic and anesthetic properties beside its sympathomimetic effect. Aim of the work is achievement of effective treatment for the neurostorm after traumatic brain injury in critically ill patients with better outcomes and decrease intensive care unit (ICU) stay.

NCT ID: NCT06353529 Not yet recruiting - Pain, Postoperative Clinical Trials

Sphenopalatine Ganglion Block for Postop Pain Management

SPGB
Start date: May 2024
Phase: Phase 4
Study type: Interventional

To assess the benefit of using an additional nerve block during minimally invasive pituitary surgery, to improve pain management after surgery. The medication (Bupivacaine) or a placebo (saline) will be injected during surgery and patients will be asked about their level of pain at multiple time points in the first 24 hours following surgery. The aim is to improve patient outcomes and reduce the need for pain medication after surgery.

NCT ID: NCT06322407 Not yet recruiting - Chronic Migraine Clinical Trials

Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult

Start date: June 2024
Phase: N/A
Study type: Interventional

To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.

NCT ID: NCT06300658 Recruiting - Hemodialysis Clinical Trials

Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery

Start date: March 9, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the role of stellate ganglion blockade (SGB) for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgery.

NCT ID: NCT06278194 Not yet recruiting - Clinical trials for Trigeminal Neuralgia

Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve branch of the trigeminal nerve. The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure. In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the procedure related with masseter muscle.

NCT ID: NCT06271707 Not yet recruiting - Esophagectomy Clinical Trials

Stellate Ganglion Block

Start date: July 1, 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

NCT ID: NCT06244056 Recruiting - Clinical trials for Stellate Ganglion Block

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Start date: February 5, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

NCT ID: NCT06241924 Recruiting - Parkinson Disease Clinical Trials

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

BAG-OSMOV
Start date: February 5, 2024
Phase: N/A
Study type: Interventional

The expression of hypokinetic and hyperkinetic motor symptoms is accompanied by pathological synchronous oscillations of neuronal activity in this cortico-subcortical network with a wide frequency range. The purpose of this research is to study cortico-subcortical oscillations and their synchronization in two pathologies emblematic of hypokinetic (Parkinson's disease) and hyperkinetic (epilepsies) phenomena using a simple motor task and comparing different situations.